Autonomic nervous system and blood pressure regulation in RGS 2-deficient mice

Volkmar Gross, Jens Tank, Michael Obst, Ralph Plehm, Kendall J. Blumer, Andrè Diedrich, Jens Jordan, and Friedrich C. Luft Max Delbrück Center for Molecular Medicine, Berlin; and Medical Faculty of the Charité, Franz Volhard Clinic, HELIOS Klinikum-Berlin, Berlin, Germany; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri; and Autonomic Dysfunction Service, Vanderbilt University, Nashville, Tennessee

[1]  F. Luft,et al.  Nitric oxide synthase expression in AT2 receptor-deficient mice after DOCA-salt. , 2004, Kidney international.

[2]  C. Julien,et al.  Assessing the sensitivity of spontaneous baroreflex control of the heart: deeper insight into complex physiology. , 2004, Hypertension.

[3]  A. Diedrich,et al.  Clonidine Improves Spontaneous Baroreflex Sensitivity in Conscious Mice Through Parasympathetic Activation , 2004, Hypertension.

[4]  C. Larminie,et al.  Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. , 2004, Brain research. Molecular brain research.

[5]  R. Karas,et al.  Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure , 2003, Nature Medicine.

[6]  H. Stauss,et al.  Heart rate variability. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  M. Morris,et al.  Oxytocinergic regulation of cardiovascular function: studies in oxytocin-deficient mice. , 2003, American journal of physiology. Heart and circulatory physiology.

[8]  S. Boehm.  Signaling via nucleotide receptors in the sympathetic nervous system. , 2003, Drug news & perspectives.

[9]  Italo Biaggioni,et al.  Sympathetic control of the circulation in hypertension: lessons from autonomic disorders , 2003, Current opinion in nephrology and hypertension.

[10]  T. Coffman,et al.  RGS2: a "turn-off" in hypertension. , 2003, The Journal of clinical investigation.

[11]  J. Penninger,et al.  Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. , 2003, The Journal of clinical investigation.

[12]  V. Somers,et al.  Arterial baroreflex function and cardiovascular variability: interactions and implications. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[13]  A. Diedrich,et al.  Heart Rate Variability and Baroreflex Function in AT2 Receptor-Disrupted Mice , 2002, Hypertension.

[14]  B. Janssen,et al.  Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[15]  W. Koch,et al.  Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. , 2002, Molecular pharmacology.

[16]  Jürgen Westermann,et al.  Simple, rapid and sensitive determination of epinephrine and norepinephrine in urine and plasma by non-competitive enzyme immunoassay, compared with HPLC method. , 2002, Clinical laboratory.

[17]  G. Jennings,et al.  Sympathetic Nerve Biology In Essential Hypertension , 2001, Clinical and experimental pharmacology & physiology.

[18]  H. Nishimatsu,et al.  Elevated Sympathetic Nervous Activity in Mice Deficient in &agr;CGRP , 2001, Circulation research.

[19]  D. Su,et al.  Blood Pressure Variability And Organ Damage , 2001, Clinical and experimental pharmacology & physiology.

[20]  T. Lohmeier.  The sympathetic nervous system and long-term blood pressure regulation. , 2001, American journal of hypertension.

[21]  H. Ehmke,et al.  Autonomic cardiovascular control in conscious mice. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  I. Whishaw,et al.  Regulation of T cell activation, anxiety, and male aggression by RGS2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J K Triedman,et al.  Phenotypic screening for heart rate variability in the mouse. , 2000, American journal of physiology. Heart and circulatory physiology.

[24]  H. Gavras,et al.  Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in catecholamine-induced vasoconstriction. , 2000, General pharmacology.

[25]  B. Janssen,et al.  Short-term and long-term blood pressure and heart rate variability in the mouse. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[26]  S. Vatner,et al.  Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsalpha. , 1998, Circulation research.

[27]  D. Clapham,et al.  Abnormal Heart Rate Regulation in GIRK4 Knockout Mice , 1998, Neuron.

[28]  S. Heximer,et al.  RGS2/G0S8 is a selective inhibitor of Gqalpha function. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C Vermeiren,et al.  Decreased heart rate variability in transgenic mice overexpressing atrial beta 1-adrenoceptors. , 1996, The American journal of physiology.

[30]  M. Böhm,et al.  Heterotrimeric G proteins in heart disease. , 1996, Cellular signalling.

[31]  J. Clairambault,et al.  Linear and non-linear analyses of heart rate variability: a minireview. , 1996, Cardiovascular research.

[32]  R. Hughson,et al.  Spontaneous cardiac baroreflex in humans. Comparison with drug-induced responses. , 1995, Hypertension.

[33]  A Mattes,et al.  PHARMFIT--a nonlinear fitting program for pharmacology. , 1991, Chronobiology international.

[34]  D. Laude,et al.  Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers. , 1990, Journal of the autonomic nervous system.

[35]  D. Levy,et al.  Cardiovascular risks: new insights from Framingham. , 1988, American heart journal.

[36]  J Strackee,et al.  Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. , 1987, The American journal of physiology.